"Enhancing prognostic accuracy in intracerebral hemorrhage: the role of serum secretoneurin and emerging biomarkers".

Intracerebral hemorrhage (ICH) is a severe stroke type with high mortality and disability rates, and traditional prognostic tools like the Glasgow Coma Scale (GCS) have limited predictive power. Emerging research suggests that serum secretoneurin could serve as a promising biomarker for ICH. Elevated secretoneurin levels have been associated with poorer outcomes and may offer more precise prognostic insights compared to conventional methods. This biomarker's potential to enhance outcome prediction underscores the need for further research to validate its efficacy and integrate it into clinical practice. Future studies should also explore additional biomarkers and advanced predictive models.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)